SELLAS Life Sciences Group (RXK3) Short Interest
XTRA • RXK3 • US81642T2096
As of Nov 3, 2026, ORTEX estimated 24.7% of free float sold short, cost to borrow 7.7%. Sign up for live short interest data.
XTRA • RXK3 • US81642T2096
As of Nov 3, 2026, ORTEX estimated 24.7% of free float sold short, cost to borrow 7.7%. Sign up for live short interest data.
This page tracks how heavily SELLAS Life Sciences Group (XTRA:RXK3) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
SELLAS Life Sciences Group (XTRA: RXK3) has a market capitalization of $1.6B. Last close €18.65 (as of 2026-11-18); 52-week range €6.88 to €18.65. ORTEX data as of 2026-11-03: short interest was 24.65% of free float and the average cost to borrow was 7.7%. Sign up for live short interest data.